Skip to main content
Published locations for Dasatinib re-challenge feasible as 2nd attempt at TKI discontinuation
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Dasatinib re-challenge feasible as 2nd attempt at TKI discontinuation
User login
Username
Password
Reset your password
/content/dasatinib-re-challenge-feasible-2nd-attempt-tki-discontinuation
/hematology-oncology/article/190762/leukemia-myelodysplasia-transplantation/dasatinib-re-challenge-feasible-2nd
/hematologytimes/article/190762/leukemia-myelodysplasia-transplantation/dasatinib-re-challenge